346434798	346434798	CD	B-NP	O
|	|	NN	I-NP	O
BSMC	BSMC	NN	I-NP	O
|	|	NN	I-NP	O
55985231	55985231	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6658898	6658898	CD	B-NP	O
|	|	CC	I-NP	O
6/16/2004	6/16/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Esophagitis	Esophagitis	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/10/2004	7/10/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/15/2004	9/15/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
STANSBURY	STANSBURY	NNP	B-NP	O
,	,	,	O	O
ELLSWORTH	ELLSWORTH	NNP	B-NP	O
458-86-28-3	458-86-28-3	CD	I-NP	O
Na	Na	NNP	I-NP	O
Port	Port	NNP	I-NP	O
Gardvi	Gardvi	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/10/04	7/10/04	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SAMLAND	SAMLAND	NNP	B-NP	O
,	,	,	O	O
ABRAHAM	ABRAHAM	NNP	B-NP	O
BENTON	BENTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
CLONAZEPAM	CLONAZEPAM	NN	B-NP	O
0.5	0.5	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/15/04	5/15/04	CD	B-NP	O
by	by	IN	B-PP	O
BLASING	BLASING	NNP	B-NP	O
,	,	,	O	O
TITUS	TITUS	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIFLUCAN	DIFLUCAN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
65644094	65644094	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLONAZEPAM	CLONAZEPAM	NNP	B-NP	O
&	&	CC	I-NP	O
FLUCONAZOLE	FLUCONAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
.	.	.	O	O

DIFLUCAN	DIFLUCAN	NN	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
FLUCONAZOLE	FLUCONAZOLE	NN	I-NP	O
-RRB-	-RRB-	SYM	O	O
100	100	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-VP	O
12	12	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
Today	Today	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
8/11	8/11	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
INDICATIONS	INDICATIONS	NNS	I-NP	O
:	:	:	O	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
suspected	suspect	VBN	B-VP	O
esophageal	esophageal	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
in	in	IN	B-PP	O
poorly	poorly	RB	B-NP	O
cnotroled	cnotrole	VBN	I-NP	O
diabetic	diabetic	JJ	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/15/04	5/15/04	CD	B-NP	O
by	by	IN	B-PP	O
SHRIMPLIN	SHRIMPLIN	NNP	B-NP	O
,	,	,	O	O
BRYANT	BRYANT	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLONAZEPAM	CLONAZEPAM	NNP	B-NP	O
&	&	CC	I-NP	O
FLUCONAZOLE	FLUCONAZOLE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLONAZEPAM	CLONAZEPAM	NNP	B-NP	O
&	&	CC	I-NP	O
FLUCONAZOLE	FLUCONAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/18/04	4/18/04	CD	B-NP	O
by	by	IN	B-PP	O
BERDAR	BERDAR	NNP	B-NP	O
,	,	,	O	O
EZRA	EZRA	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90054223	90054223	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/18/04	4/18/04	CD	B-NP	O
by	by	IN	B-PP	O
INGARGIOLA	INGARGIOLA	NNP	B-NP	O
,	,	,	O	O
DENNY	DENNY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
16065157	16065157	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NN	B-NP	O
.	.	.	O	O

MOM	MOM	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
MAGNESIUM	MAGNESIUM	NN	I-NP	O
HYDROXIDE	HYDROXIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
30	30	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NNP	B-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/11	8/11	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
,	,	,	O	O
Upset	Upset	NNP	B-NP	O
Stomach	Stomach	NNP	I-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	B-protein
TAB	TAB	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Upset	Upset	NNP	I-NP	I-protein
Stomach	Stomach	NNP	I-NP	I-protein
PROTONIX	PROTONIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
LIPITOR	LIPITOR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
ATENOLOL	ATENOLOL	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ECASA	ECASA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
REMERON	REMERON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MIRTAZAPINE	MIRTAZAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
CELEXA	CELEXA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CITALOPRAM	CITALOPRAM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
call	call	VB	B-VP	O
you	you	PRP	B-NP	O
MD	MD	NNP	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
esophagitis	esophagitis	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
depression	depression	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Esophagitis	Esophagitis	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
NIDDM	NIDDM	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
cad	cad	NN	I-NP	O
s/p	s/p	NN	I-NP	O
6/22	6/22	CD	I-NP	O
cath	cath	NN	I-NP	O
with	with	IN	B-PP	O
Lcirc	Lcirc	NN	B-NP	O
stent	stent	JJ	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
MIBI	MIBI	NN	B-NP	B-DNA
2/8/04	2/8/04	CD	I-NP	I-DNA
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
reversibility	reversibility	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
NID	NID	NNP	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Depression	Depression	NN	B-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
circumflex	circumflex	NN	I-NP	O
stent	stent	NN	I-NP	O
2002	2002	CD	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Cath	Cath	NN	B-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
showed	show	VBD	B-VP	O
2-V	2-V	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
mibi	mibi	NN	I-NP	O
being	be	VBG	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
.	.	.	O	O

Presented	Present	VBN	B-VP	O
with	with	IN	B-PP	O
36-48	36-48	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
deep	deep	JJ	B-NP	O
boring/squeezing	boring/squeezing	NN	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
left	left	JJ	I-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
xyphoid	xyphoid	JJ	B-NP	B-DNA
region	region	NN	I-NP	I-DNA
,	,	,	O	O
suprasternal	suprasternal	JJ	B-NP	O
notch	notch	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
is	be	VBZ	B-VP	O
reproducible	reproducible	JJ	B-ADJP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
radiate	radiate	VB	I-VP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
nausea/vomiting	nausea/vomiting	NN	B-NP	O
.	.	.	O	O

Unrelieved	Unrelieve	VBN	B-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

Minimal	Minimal	JJ	B-NP	O
relief	relief	NN	I-NP	O
with	with	IN	B-PP	O
morphine	morphine	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
relief	relief	NN	I-NP	O
with	with	IN	B-PP	O
maalox	maalox	NN	B-NP	O
,	,	,	O	O
po	po	NN	B-NP	O
lidocaine	lidocaine	NN	I-NP	O
susp	susp	NN	I-NP	O
.	.	.	O	O

First	First	NNP	B-NP	O
set	set	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
Nl	Nl	NN	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
wall	wall	NN	I-NP	O
compression	compression	NN	I-NP	O
over	over	IN	B-ADVP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
ribs	rib	NNS	I-NP	O
reproduces	reproduce	VBZ	B-VP	O
pain-no	pain-no	JJ	B-NP	O
superficial	superficial	JJ	I-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
swelling	swelling	NN	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
CTAB	CTAB	NN	I-NP	B-protein
.	.	.	O	O

Abd	Abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
without	without	IN	B-PP	O
C/C/E	C/C/E	NN	B-NP	B-protein
;	;	:	O	O
pulses	pulse	NNS	B-NP	O
symmetric	symmetric	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	O
79	79	CD	I-NP	O
bpm	bpm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
and	and	CC	I-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O
V3-V5	V3-V5	NN	I-NP	O
,	,	,	O	O
inverted	invert	VBD	B-VP	O
Ts	T	NNS	B-NP	O
in	in	IN	B-PP	O
V3-V5	V3-V5	NN	B-NP	O
.	.	.	O	O

C/W	C/W	NN	B-NP	O
EKG	EKG	NN	I-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2004	2004	CD	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
effusions	effusion	NNS	B-NP	O
,	,	,	O	O
infiltrates	infiltrate	NNS	B-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
bony	bony	NN	I-NP	O
structures	structure	NNS	I-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
diseae	diseae	NNS	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

mibi	mibi	NNS	B-NP	O
on	on	IN	B-PP	O
7/28	7/28	CD	B-NP	O
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
without	without	IN	B-PP	O
reversibility	reversibility	NN	B-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issue	issue	NN	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
.	.	.	O	O

SSI	SSI	NNP	B-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Psych	Psych	NNP	B-NP	O
:	:	:	O	O
MDD-continue	MDD-continue	JJ	B-NP	O
remeron	remeron	NN	I-NP	O
,	,	,	O	O
celexa	celexa	NN	B-NP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Esophagitis	Esophagitis	NN	B-NP	O
responded	respond	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
to	to	TO	B-PP	O
KBL	KBL	NN	B-NP	B-cell_type
and	and	CC	I-NP	O
diflucan	diflucan	NN	I-NP	O
.	.	.	O	O

Tolerating	Tolerate	VBG	B-VP	O
PO	PO	NN	B-NP	B-protein
on	on	IN	B-PP	O
AM	AM	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	O	O
complete	complete	JJ	B-NP	O
two	two	CD	I-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Fluconazole	Fluconazole	NN	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
outpatient	outpatient	NN	B-NP	O
EGD	EGD	NN	I-NP	O
if	if	IN	B-SBAR	O
sx	sx	NN	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
improve	improve	VB	I-VP	O
with	with	IN	B-PP	O
tx	tx	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ELIZARRARAS	ELIZARRARAS	NN	B-NP	O
,	,	,	O	O
HERSCHEL	HERSCHEL	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AZ041	AZ041	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/10/04	7/10/04	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
06	06	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

